|
T-Cell Leukemia Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 93 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H1, 2012" provides data on the T-Cell Leukemia clinical trial scenario. This report provides elemental.....
Introduction GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H1, 2012" provides data on the T-Cell Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on T-Cell Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating T-Cell Leukemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 T-Cell Leukemia 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials by Country 8 Top Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Nations 14 Clinical Trials in G7 Nations by Trial Status 15 Clinical Trials by Phase 16 In Progress Trials by Phase 17 Clinical Trials by Trial Status 18 Unaccomplished Trials of T-Cell Leukemia 19 Subjects Recruited Over a Period of Time 21 Prominent Sponsors 22 Top Companies Participating in T-Cell Leukemia Therapeutics Clinical Trials 24 Prominent Drug Comparison 25 Clinical Trial Profiles 26 Clinical Trial Overview of Top Companies 26 BioCryst Pharmaceuticals, Inc. 26 Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 26 Kyowa Hakko Kirin Co., Ltd. 27 Clinical Trial Overview of Kyowa Hakko Kirin Co., Ltd. 27 Shape Pharmaceuticals, Inc 28 Clinical Trial Overview of Shape Pharmaceuticals, Inc 28 Bristol-Myers Squibb Company 29 Clinical Trial Overview of Bristol-Myers Squibb Company 29 Celgene Corporation 30 Clinical Trial Overview of Celgene Corporation 30 Pfizer Inc. 31 Clinical Trial Overview of Pfizer Inc. 31 Novartis AG 32 Clinical Trial Overview of Novartis AG 32 Merck & Co., Inc. 33 Clinical Trial Overview of Merck & Co., Inc. 33 Clinical Trial Overview of Top Universities / Institutes / Hospitals 34 Fred Hutchinson Cancer Research Center 34 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 34 Ohio State University Comprehensive Cancer Center 35 Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 35 Therapeutic Advances in Childhood Leukemia Consortium 36 Clinical Trial Overview of Therapeutic Advances in Childhood Leukemia Consortium 36 Scott & White Healthcare 37 Clinical Trial Overview of Scott & White Healthcare 37 Kagoshima University 38 Clinical Trial Overview of Kagoshima University 38 Osaka City University 39 Clinical Trial Overview of Osaka City University 39 Mayo Clinic 40 Clinical Trial Overview of Mayo Clinic 40 Memorial Sloan Kettering Cancer Center 41 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 41 University of Nebraska 42 Clinical Trial Overview of University of Nebraska 42 Columbia University 43 Clinical Trial Overview of Columbia University 43 Northwestern University 44 Clinical Trial Overview of Northwestern University 44 Thomas Jefferson University 45 Clinical Trial Overview of Thomas Jefferson University 45 St. Jude Children’s Research Hospital, Inc. 46 Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc. 46 Case Comprehensive Cancer Center 47 Clinical Trial Overview of Case Comprehensive Cancer Center 47 University Hospital Freiburg 48 Clinical Trial Overview of University Hospital Freiburg 48 Albert Einstein College of Medicine of Yeshiva University 49 Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University 49 National Institute of Neurological Disorders and Stroke 50 Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 50 Johann Wolfgang Goethe University Hospitals 51 Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 51 Washington University School of Medicine 52 Clinical Trial Overview of Washington University School of Medicine 52 University of Alabama at Birmingham 53 Clinical Trial Overview of University of Alabama at Birmingham 53 Five Key Clinical Profiles 54 Appendix 89 Abbreviations 89 Definitions 89 Research Methodology 91 Secondary Research 91 About GlobalData 92 Contact Us 92 Disclaimer 92 Source 93 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7 T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 T-Cell Leukemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 T-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10 T-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11 T-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2012* 12 T-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 13 T-Cell Leukemia Therapeutics Clinical Trials, G7 Countries, 2012* 14 T-Cell Leukemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15 T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Phase, 2012* 16 T-Cell Leukemia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 17 T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 18 T-Cell Leukemia Therapeutics Market, Global, Suspended Clinical Trials, 2012* 19 T-Cell Leukemia Therapeutics Market, Global, Terminated Clinical Trials, 2012* 20 T-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 21 T-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 23 T-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 24 T-Cell Leukemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 25 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2012* 26 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyowa Hakko Kirin Co., Ltd., 2012* 27 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shape Pharmaceuticals, Inc, 2012* 28 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 29 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 30 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 31 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 32 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 33 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 34 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2012* 35 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Therapeutic Advances in Childhood Leukemia Consortium, 2012* 36 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Scott & White Healthcare, 2012* 37 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kagoshima University, 2012* 38 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka City University, 2012* 39 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 40 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 41 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2012* 42 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2012* 43 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 44 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2012* 45 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2012* 46 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 47 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2012* 48 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2012* 49 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2012* 50 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2012* 51 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2012* 52 T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2012* 53 List of Figures T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7 T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 T-Cell Leukemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 T-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10 T-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11 T-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12 T-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 13 T-Cell Leukemia Therapeutics Clinical Trials, G7 Countries (%), 2012* 14 T-Cell Leukemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15 T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 16 T-Cell Leukemia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 17 T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 18 T-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 21 T-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 22 T-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 24 T-Cell Leukemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 25 GlobalData Methodology 91 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
